Medtronic AneuRx Endovascular AAA Graft Should Be Approved - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's AneuRx minimally invasive endovascular graft for abdominal aortic aneurysm repair was successfully implanted in 98% of the 416 patients treated in the company's pivotal trial to support premarket approval, study investigators said.